Market Cap Overview
Market Cap
$12.88M
Share Price
$0.46
Shares Outstanding
28.01M
What is NextCure's Market Cap?
NextCure's current Market Cap as of today is $12.88M.
Understanding Market Capitalization
Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.
- It provides a straightforward method of gauging a company's size.
- Market Cap can be used to compare companies within the same industry.
How is Market Cap calculated?
Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:
Market Cap = Current Share Price × Total Shares Outstanding
In the case of NextCure, the market cap is calculated as $0.46 x 28.01M shares = $12.88M.
As a Micro Cap company, NextCure is a very small company that may be in its early stages.
NextCure Historical Market Cap
NextCure Market Cap vs Enterprise Value
Understanding Market Cap vs. Enterprise Value
While market cap represents the equity value of NextCure, enterprise value provides a more complete picture of the company's total value by including debt and cash:
Enterprise Value = Market Cap + Total Debt - Cash and Equivalents
NextCure's enterprise value as of December 31, 2024 (Q4 2024) is calculated as:
- Market Cap: $12.88M
- Total Debt: $5.95M
- Cash and Equivalents: $27.73M
- Enterprise Value: $-208.63K
The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A lower enterprise value indicates a strong net cash position.
NextCure Annual Market Cap History
| Year | Market Cap | Change |
|---|---|---|
| 2025 | $12.88M | -40.25% |
| 2024 | $21.56M | -32.06% |
| 2023 | $31.73M | -18.88% |
| 2022 | $39.12M | -76.39% |
| 2021 | $165.70M | -44.79% |
| 2020 | $300.10M | -66.06% |
| 2019 | $884.13M | 342.58% |
| 2018 | $199.77M | 0.00% |
| 2017 | $199.77M | N/A |
Frequently Asked Questions
Related Metrics
Explore detailed financial metrics and analysis for NXTC.